Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback